MarketCap
Facebook
X
TelegramQuarterly report 2022-Q2
added 12-16-2023
Change Healthcare ROCE Ratio 2011-2026 | CHNG
Annual ROCE Ratio Change Healthcare
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 3.08 | -7.86 | -0.09 | -0.01 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.08 | -7.86 | -1.22 |
Quarterly ROCE Ratio Change Healthcare
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.54 | 2.6 | 2.94 | 2.58 | 4.52 | 5.58 | 5.34 | 1.81 | 1.57 | -0.37 | -3.01 | -2.79 | -2.58 | -2.59 | -0.06 | -0.04 | -0.02 | -0.01 | -0.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.58 | -3.01 | 0.95 |
ROCE Ratio of other stocks in the Health information services industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-11.97 | - | 0.29 % | $ 206 M |  USA |
 |
Cerner Corporation
CERN
|
19.24 | - | - | $ 27.9 B | USA |
 |
HealthEquity
HQY
|
10.0 | $ 82.63 | 0.55 % | $ 7.12 B | USA |
 |
Computer Programs and Systems
CPSI
|
-22.83 | - | 4.4 % | $ 133 M | USA |
 |
iCAD
ICAD
|
-21.85 | - | - | $ 102 M | USA |
 |
Covetrus
CVET
|
-1.52 | - | - | $ 2.94 B | USA |
 |
Akerna Corp.
KERN
|
-20.09 | - | - | $ 161 M | USA |
 |
Castlight Health, Inc.
CSLT
|
-9.43 | - | -7.28 % | $ 227 M | USA |
 |
HMS Holdings Corp.
HMSY
|
7.6 | - | - | $ 3.29 B | USA |
 |
Inovalon Holdings, Inc.
INOV
|
3.97 | - | - | $ 6.37 B | USA |
 |
Evolent Health
EVH
|
0.42 | $ 3.91 | -2.01 % | $ 366 M | USA |
 |
GoodRx Holdings
GDRX
|
9.09 | $ 2.56 | 2.4 % | $ 987 M | USA |
 |
10x Genomics
TXG
|
-35.8 | $ 22.01 | 1.66 % | $ 2.58 B | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
5.48 | - | -10.39 % | $ 886 M | USA |
 |
MTBC
MTBC
|
19.06 | - | -0.58 % | $ 51.7 M | USA |
 |
1Life Healthcare
ONEM
|
-14.09 | - | - | $ 3.37 B | USA |
 |
Premier
PINC
|
0.07 | - | - | $ 2.33 B | USA |
 |
NextGen Healthcare
NXGN
|
2.97 | - | - | $ 1.6 B | USA |
 |
Health Catalyst
HCAT
|
-65.45 | $ 1.6 | 1.91 % | $ 112 M | USA |
 |
OptimizeRx Corporation
OPRX
|
-20.86 | $ 6.63 | -2.07 % | $ 114 M | USA |
 |
Schrödinger
SDGR
|
-45.84 | $ 12.87 | -0.23 % | $ 945 M | USA |
 |
Phreesia
PHR
|
-1.96 | $ 9.65 | -0.21 % | $ 576 M | USA |
 |
R1 RCM
RCM
|
42.02 | - | - | $ 3.81 B | USA |
 |
Teladoc Health
TDOC
|
-18.98 | $ 6.66 | 0.45 % | $ 1.17 B | USA |
 |
Signify Health
SGFY
|
1.16 | - | -0.02 % | $ 7.21 B | USA |
 |
Streamline Health Solutions
STRM
|
-64.14 | - | - | $ 21.4 M | USA |
 |
NantHealth
NH
|
22.77 | - | -46.64 % | $ 10.4 M | USA |
 |
SCWorx Corp.
WORX
|
-27.93 | - | - | $ 7.71 M | USA |
 |
American Well Corporation
AMWL
|
-44.69 | $ 6.36 | -0.93 % | $ 102 M | USA |
 |
Tabula Rasa HealthCare
TRHC
|
120.94 | - | - | $ 255 M | USA |
 |
HealthStream
HSTM
|
5.92 | $ 24.36 | 14.64 % | $ 740 M | USA |
 |
Omnicell
OMCL
|
0.03 | $ 43.56 | 0.28 % | $ 2.01 B | USA |
 |
Progyny
PGNY
|
3.74 | $ 18.98 | 0.37 % | $ 1.63 B | USA |
 |
So-Young International
SY
|
-16.35 | $ 3.16 | 5.33 % | $ 246 M |  China |
 |
Veeva Systems
VEEV
|
12.7 | $ 171.19 | 0.57 % | $ 28 B | USA |
 |
Zhongchao
ZCMD
|
-0.98 | $ 2.2 | -0.9 % | $ 7.52 M | China |